These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24546774)

  • 1. Therapy of adrenocortical cancer with o,p' DDD in two children.
    FISHER DA; PANOS TC; MELBY JC
    J Clin Endocrinol Metab; 1963 Feb; 23():218-21. PubMed ID: 24546774
    [No Abstract]   [Full Text] [Related]  

  • 2. TREATMENT OF ADRENOCORTICAL CANCER WITH O,P'-DDD.
    NETTO AD; WAJCHENBERG BL; RAVAGLIA C; PEREIRA VG; SHNAIDER J; PUPO AA; CINTRA AB
    Ann Intern Med; 1963 Jul; 59():74-8. PubMed ID: 14042612
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and therapeutic observations in the adrenal cancer: a report on 7 patients treated with o,p'-DDD.
    MOLNAR GD; MATTOX VR; BAHN RC
    Cancer; 1963 Feb; 16():259-68. PubMed ID: 13935915
    [No Abstract]   [Full Text] [Related]  

  • 4. ADRENOCORTICAL CARCINOMA TREATED WITH O,P' -DDD.
    MONTGOMERY DA; WELBOURN RB
    Br Med J; 1965 May; 1(5446):1356-8. PubMed ID: 14280300
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
    Kroiss M; Plonné D; Kendl S; Schirmer D; Ronchi CL; Schirbel A; Zink M; Lapa C; Klinker H; Fassnacht M; Heinz W; Sbiera S
    Eur J Endocrinol; 2016 Mar; 174(3):343-53. PubMed ID: 26671975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
    Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
    Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of o,p'-DDD therapy on plasma cholesterol in adrenal carcinoma.
    MOLNAR GD; NUNN SL; TAUXE WN
    Proc Staff Meet Mayo Clin; 1961 Nov; 36():618-20. PubMed ID: 14475247
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-dimensional chromatography for enantiomeric analysis of mitotane and its metabolite o,p'-DDA in patients with adrenocortical carcinoma indicates enantioselective metabolism.
    Stadler G; de Almeida Veiga A; Rita Corso C; Bach de Assis C; de Toledo Nogueira B; Regina Rocha Martins L; Cruz Bonk B; Lada Degaut Pontes F; Cavalcante de Figueiredo B; Mera de Souza L
    Bioorg Chem; 2023 Dec; 141():106835. PubMed ID: 37713949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.
    Theile D; Haefeli WE; Weiss J
    Endocrine; 2015 Aug; 49(3):842-53. PubMed ID: 25542188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma.
    Cusato J; De Francia S; Allegra S; Carrella S; Pirro E; Piccione FM; De Martino F; Ferrero A; Daffara FC; Terzolo M; Berruti A; Di Carlo F; Tampellini M; D'Avolio A
    J Pharm Pharmacol; 2017 Nov; 69(11):1524-1530. PubMed ID: 28809444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma.
    Hescot S; Seck A; Guerin M; Cockenpot F; Huby T; Broutin S; Young J; Paci A; Baudin E; Lombès M
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2890-8. PubMed ID: 26120791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid and mineralocorticoid pathways in two adrenocortical carcinomas: comparison of the effects of o,p'-dichlorodiphenyldichloroethane, aminoglutethimide and 2-p-aminophenyl-2-phenylethylamine in vitro.
    Touitou Y; Bogdan A; Auzeby A; Dommergues JP
    J Endocrinol; 1979 Jul; 82(1):87-94. PubMed ID: 479738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
    Barzon L; Fallo F; Sonino N; Daniele O; Boscaro M
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1488-9. PubMed ID: 10199802
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients.
    Garg MB; Sakoff JA; Ackland SP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2201-5. PubMed ID: 21719363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ortho, para'DDD on steroid hormone metabolites in adrenocortical carcinoma.
    GALLAGHER TF; FUKUSHIMA DK; HELIMAN L
    Metabolism; 1962 Nov; 11():1155-61. PubMed ID: 13960358
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer.
    Lindhe O; Skogseid B
    Horm Metab Res; 2010 Sep; 42(10):725-30. PubMed ID: 20665429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and chemical response of functioning adrenal cortical carcinoma to ortho, para'-DDD.
    VERDON TA; BRUTON J; HERMAN RH; BEISEL WR
    Metabolism; 1962 Feb; 11():226-34. PubMed ID: 13925398
    [No Abstract]   [Full Text] [Related]  

  • 18. o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement.
    Hogan TF; Citrin DL; Johnson BM; Nakamura S; Davis TE; Borden EC
    Cancer; 1978 Nov; 42(5):2177-81. PubMed ID: 719602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment for adrenocortical carcinoma].
    Iihara M; Obara T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):342-5. PubMed ID: 15045937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of o,p'-DDD and Li+ on apoptotic DNA fragmentation in conventionally normal and tumour tissues of human adrenal cortex.
    Pushkarev VM; Tronko ND; Kostyuchenko NN; Mikosha AS
    Ukr Biokhim Zh (1999); 2007; 79(2):44-9. PubMed ID: 18030749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.